These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 96023

  • 1. Mode of action of anti-tubercular drugs.
    Santhanam K, Venkitasubramanian TA.
    Indian J Chest Dis Allied Sci; 1977 Oct; 19(4):192-207. PubMed ID: 96023
    [No Abstract] [Full Text] [Related]

  • 2. Incidence of resistance to primary and secondary antituberculosis drugs in isolates of M. tuberculosis from cases of pulmonary tuberculosis.
    Kothadia SN, Sengupta SR.
    Indian J Chest Dis Allied Sci; 1984 Oct; 26(3):163-6. PubMed ID: 6443608
    [No Abstract] [Full Text] [Related]

  • 3. [Interaction of antitubercular agents. I. Combined action of rifampicin, isonicotinic acid hydrazide, streptomycin and para-aminosalicylic acid on the growth of strains of tubercle bacilli].
    Janowiec M, Zwolska-Kwiek Z, Wiśniewska A, Wróblewska H.
    Pneumonol Pol; 1977 Jun; 45(6):425-30. PubMed ID: 406600
    [No Abstract] [Full Text] [Related]

  • 4. Fluoroquinolone-resistant tuberculosis at a medical centre in Taiwan, 2005-10.
    Lai CC, Tan CK, Huang YT, Liao CH, Hsueh PR.
    J Antimicrob Chemother; 2011 Oct; 66(10):2437-8. PubMed ID: 21798881
    [No Abstract] [Full Text] [Related]

  • 5. [Mechanisms of the action of drugs in the short-course chemotherapy].
    Mitchison DA.
    Bull Int Union Tuberc; 1985 Oct; 60(1-2):36-40. PubMed ID: 2416374
    [No Abstract] [Full Text] [Related]

  • 6. [Testing Mycobacterium tuberculosis for drug sensitivity using different methods].
    Skriagina EM, Zalutskaia OM, Roth A, Mauch H, Nikolenko EN.
    Probl Tuberk; 2001 Oct; (5):43-5. PubMed ID: 11588962
    [Abstract] [Full Text] [Related]

  • 7. [Primary resistance of Mycobacterium tuberculosis in the province of Vizcaya].
    Echeverría MJ, Ayarza R, Jiménez MS, López de Goicoechea MJ, Berdonces P, Ibarretxebea AB.
    Rev Esp Quimioter; 1999 Jun; 12(2):152-3. PubMed ID: 10562678
    [No Abstract] [Full Text] [Related]

  • 8. Growth inhibition of tubercle bacilli after pulsed exposures to combinations of antituberculous drugs.
    Beggs WH.
    Res Commun Chem Pathol Pharmacol; 1975 Jul; 11(3):487-90. PubMed ID: 807961
    [Abstract] [Full Text] [Related]

  • 9. [Study of primary resistance to antitubercular agents in the Sousse region, 1981-1990].
    Benzarti M, Garrouche A, Jerray M, Hayouni A, Maalel K, Klabi N.
    Tunis Med; 1996 Jan; 74(1):23-7. PubMed ID: 9507309
    [No Abstract] [Full Text] [Related]

  • 10. [Determination of resistance of Mycobacterium tuberculosis against isonicotinic acid hydrazide, streptomycin, para-aminosalicylic acid, ethionamide, ethambutol and rifampicin using the 32 P incorporation test].
    Reutgen H.
    Acta Biol Med Ger; 1973 Jan; 30(3):309-16. PubMed ID: 4202698
    [No Abstract] [Full Text] [Related]

  • 11. The "in vitro" activity of rifampicin compared with ethambutol, capreomycin and isoniazid.
    Steinbrück PW.
    Acta Tuberc Pneumol Belg; 1969 Jan; 60(3):413-6. PubMed ID: 4984421
    [No Abstract] [Full Text] [Related]

  • 12. [Response to the short-course chemotherapy in patients presenting initial resistance].
    Mitchison DA.
    Bull Int Union Tuberc; 1985 Jan; 60(1-2):41-3. PubMed ID: 2416375
    [No Abstract] [Full Text] [Related]

  • 13. Trends in drug resistance of mycobacterium tuberculosis.
    Hejny J.
    Indian J Chest Dis Allied Sci; 1982 Jan; 24(2-3):190-4. PubMed ID: 6819998
    [No Abstract] [Full Text] [Related]

  • 14. Mycobacterium resistance to antimycobacterial reagent.
    Aghandous R, Zouhdi M, Zizi M, Errami M, Idrissi L.
    Therapie; 1999 Jan; 54(5):623-5. PubMed ID: 10667100
    [Abstract] [Full Text] [Related]

  • 15. Rationale for chemotherapy of tuberculosis and current recommendations.
    Kumar L.
    Indian Pediatr; 1992 Nov; 29(11):1337-9. PubMed ID: 1294486
    [No Abstract] [Full Text] [Related]

  • 16. [Ultrastructural change in Mycobacterium tuberculosis under the influence of antibacterial preparations (a review of the literature)].
    Kozulitsyna TI, Kozlova NV.
    Probl Tuberk; 1979 Oct; (10):49-57. PubMed ID: 116217
    [No Abstract] [Full Text] [Related]

  • 17. Primary drug resistance: A continuing study of tubercle bacilli in a veteran population within the United States. VI. Initial observations on the incidence of resistance to rifampin and ethambutol.
    Hobby GL, Johnson PM, Boytar-Papirnyik V, Wilber J.
    Am Rev Respir Dis; 1969 May; 99(5):777-9. PubMed ID: 4978401
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antituberculous drug susceptibility testing of Mycobacterium bovis BCG strain Montréal.
    Rousseau P, Dupuis M.
    Can J Microbiol; 1990 Oct; 36(10):735-7. PubMed ID: 2253115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.